Smith MA - Search Results

1

Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover.

Zhu X, Castellani RJ, Moreira PI, Aliev G, Shenk JC, Siedlak SL, Harris PLR, Fujioka H, Sayre LM, Szweda PA, Szweda LI, Smith MA, Perry G. Zhu X, et al. Among authors: smith ma. Free Radic Biol Med. 2012 Feb 1;52(3):699-704. doi: 10.1016/j.freeradbiomed.2011.11.004. Epub 2011 Nov 12. Free Radic Biol Med. 2012. PMID: 22137893 Free PMC article.

2

High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal.

Wataya T, Nunomura A, Smith MA, Siedlak SL, Harris PL, Shimohama S, Szweda LI, Kaminski MA, Avila J, Price DL, Cleveland DW, Sayre LM, Perry G. Wataya T, et al. Among authors: smith ma. J Biol Chem. 2002 Feb 15;277(7):4644-8. doi: 10.1074/jbc.M110913200. Epub 2001 Dec 3. J Biol Chem. 2002. PMID: 11733539 Free article.

3

Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans.

Castellani RJ, Perry G, Siedlak SL, Nunomura A, Shimohama S, Zhang J, Montine T, Sayre LM, Smith MA. Castellani RJ, et al. Among authors: smith ma. Neurosci Lett. 2002 Feb 8;319(1):25-8. doi: 10.1016/s0304-3940(01)02514-9. Neurosci Lett. 2002. PMID: 11814645

4

Causes and consequences of oxidative stress in Alzheimer's disease.

Smith MA, Perry G, Pryor WA. Smith MA, et al. Free Radic Biol Med. 2002 Jun 1;32(11):1049. doi: 10.1016/s0891-5849(02)00793-1. Free Radic Biol Med. 2002. PMID: 12031888 No abstract available.

5

Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases?

Perry G, Nunomura A, Hirai K, Zhu X, Pérez M, Avila J, Castellani RJ, Atwood CS, Aliev G, Sayre LM, Takeda A, Smith MA. Perry G, et al. Among authors: smith ma. Free Radic Biol Med. 2002 Dec 1;33(11):1475-9. doi: 10.1016/s0891-5849(02)01113-9. Free Radic Biol Med. 2002. PMID: 12446204 Review.

6

Distribution, levels, and activation of MEK1 in Alzheimer's disease.

Zhu X, Sun Z, Lee HG, Siedlak SL, Perry G, Smith MA. Zhu X, et al. Among authors: smith ma. J Neurochem. 2003 Jul;86(1):136-42. doi: 10.1046/j.1471-4159.2003.01820.x. J Neurochem. 2003. PMID: 12807433 Free article.

7

Hydroxynonenal, toxic carbonyls, and Alzheimer disease.

Liu Q, Raina AK, Smith MA, Sayre LM, Perry G. Liu Q, et al. Among authors: smith ma. Mol Aspects Med. 2003 Aug-Oct;24(4-5):305-13. doi: 10.1016/s0098-2997(03)00025-6. Mol Aspects Med. 2003. PMID: 12893008 Review.

8

Tau modifiers as therapeutic targets for Alzheimer's disease.

Liu Q, Lee HG, Honda K, Siedlak SL, Harris PL, Cash AD, Zhu X, Avila J, Nunomura A, Takeda A, Smith MA, Perry G. Liu Q, et al. Among authors: smith ma. Biochim Biophys Acta. 2005 Jan 3;1739(2-3):211-5. doi: 10.1016/j.bbadis.2004.06.021. Biochim Biophys Acta. 2005. PMID: 15615639 Free article. Review.

9

Mitochondrial failures in Alzheimer's disease.

Zhu X, Smith MA, Perry G, Aliev G. Zhu X, et al. Among authors: smith ma. Am J Alzheimers Dis Other Demen. 2004 Nov-Dec;19(6):345-52. doi: 10.1177/153331750401900611. Am J Alzheimers Dis Other Demen. 2004. PMID: 15633943 Free PMC article. Review.

10

Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations.

Liu Q, Smith MA, Avilá J, DeBernardis J, Kansal M, Takeda A, Zhu X, Nunomura A, Honda K, Moreira PI, Oliveira CR, Santos MS, Shimohama S, Aliev G, de la Torre J, Ghanbari HA, Siedlak SL, Harris PL, Sayre LM, Perry G. Liu Q, et al. Among authors: smith ma. Free Radic Biol Med. 2005 Mar 15;38(6):746-54. doi: 10.1016/j.freeradbiomed.2004.11.005. Free Radic Biol Med. 2005. PMID: 15721985

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,100 results

Search Page